Top performing companies on Nasdaq Biotech Index 2020

Published by
Matej Mikulic,
Feb 14, 2022
In 2020, the top company on the Nasdaq Biotech Index by largest gain based on full year percent change was Novavax, with some 2,700 percent. Novavax, will start submitting its COVID-19 vaccine for approval in Q3 2021.

Leading companies by gain on the Nasdaq Biotech Index in 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

January 2021

Region

Worldwide

Survey time period

2020

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Small and medium-sized biotech companies "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Small and medium-sized biotech companies

Biotech market

6

SME financing

6

Research & development

5

Growth

4

BioNTech vs. Moderna

8

Comparison of COVID-19 vaccines

5

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

Small and medium-sized biotech companiesGlobal pharmaceutical industryBiotech drugsTop pharmaceutical drugsBiotechnology in Europe
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.